NASDAQ:SLNO

Soleno Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy SLNO

*Your capital is at risk

$53.01

+0 (+0%)

At Close: Jun 23, 2026

Soleno Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.72. In total, the insiders bought 558.46K and sold 2.5M SLNO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-64.72
● Buy	558.46K shares
● Sell	2.5M shares
19% Buy Activity Weak Negative Correlation
Sell Signal High Confidence May 18, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -64.72. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (19% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Manning Meredith Chief Commercial Officer	Officer	29 200 Value: $1.44M
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Norrett Kevin Chief Business Officer	Officer	64 286 Value: $3.04M
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Sinclair Andrew Director	Director	10 000 Value: $52.5K
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Sinclair Andrew Director	Director	2 124 Value: $32.5K
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Volck Birgitte Director	Director	10 000 Value: $52.5K
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Volck Birgitte Director	Director	2 124 Value: $32.5K
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Volck Birgitte Director	Director	1 333 Value: $52.6K
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Yen Kristen See Remarks	Officer	16 000 Value: $587.2K
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Yen Kristen See Remarks	Officer	2 445 Value: $12.5K
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Yen Kristen See Remarks	Officer	666 Value: $34.1K
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Yen Kristen See Remarks	Officer	4 999 Value: $120.0K
May 18, 2026 Sell	Common Stock D-Return	Yen Kristen See Remarks	Officer	37 639 Value: $0
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Anish Bhatnagar Chief Executive Officer	CEO / President	52 709 Value: $127.0K
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Anish Bhatnagar Chief Executive Officer	CEO / President	8 473 Value: $43.2K
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Yen Kristen See Remarks	Officer	11 667 Value: $28.1K
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Volck Birgitte Director	Director	635 Value: $32.5K
May 18, 2026 Sell	Stock Option (Right to buy) D-Return	Sinclair Andrew Director	Director	1 333 Value: $31.4K
May 18, 2026 Sell	Common Stock D-Return	Pauls Matthew Director	Director	10 491 Value: $0
May 18, 2026 Sell	Common Stock D-Return	Manning Meredith Chief Commercial Officer	Officer	64 507 Value: $0
May 18, 2026 Sell	Common Stock D-Return	Joshi Manher Chief Development Officer	Officer	20 171 Value: $0
May 18, 2026 Sell	Employee Stock Option (Right to buy) D-Return	Anish Bhatnagar Chief Executive Officer	CEO / President	23 332 Value: $1.19M
Mar 27, 2026 Sell	Common Stock S-Sale	Manning Meredith Chief Commercial Officer	Officer	2 100 Value: $65.2K
Mar 27, 2026 Sell	Common Stock S-Sale	Huang Michael F. Sr. Vp Of Clinical Development	Officer	1 838 Value: $57.0K
Mar 27, 2026 Sell	Common Stock S-Sale	Huang Michael F. Sr. Vp Of Clinical Development	Officer	488 Value: $15.5K
Mar 27, 2026 Sell	Common Stock S-Sale	Huang Michael F. Sr. Vp Of Clinical Development	Officer	4 256 Value: $127.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks